Pharming Group NV Capital Reinvestment Ratio
Pharming Group NV capital reinvestment ratio. Pharming Group NV (PHAR) has a Capital Reinvestment Ratio of 0.15x as of March 2026, meaning it reinvests 0% of its operating cash flow ($1.63 Million) in capital expenditures ($238.86K). Check Pharming Group NV total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pharming Group NV (2017–2025)
Capital reinvestment ratio of Pharming Group NV from 2017 to 2025. This chart tracks Pharming Group NV's Capital Reinvestment Ratio across 7 annual periods. Also explore net asset momentum of Pharming Group NV to track the company's year-over-year net asset growth rate.
Pharming Group NV Capital Reinvestment Ratio by Year (2017–2025)
Pharming Group NV capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see how efficiently does Pharming Group NV generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $50.07 Million | $751.09K | ▼ -83.0% |
| 2022 | 0.09x | $22.46 Million | $1.98 Million | ▼ -80.1% |
| 2021 | 0.44x | $37.84 Million | $16.72 Million | ▲ +141.4% |
| 2020 | 0.18x | $83.63 Million | $15.30 Million | ▼ -46.7% |
| 2019 | 0.34x | $74.15 Million | $25.45 Million | ▲ +267.7% |
| 2018 | 0.09x | $46.19 Million | $4.31 Million | ▼ -41.0% |
| 2017 | 0.16x | $45.84 Million | $7.25 Million | — |